The impact of osteochondritis dissecans (OCD) of the knee on a patient's physical function and quality of life has not previously been quantified. Measurements of health-related quality of life (HRQoL) seek to capture the impact of a health condition and its treatment on a patient's physical, emotional, and social well-being.^[@bibr16-2325967119886591]^ Although not well documented in the orthopaedic literature, HRQoL assessments provide greater comparability across different diseases, are a source of useful data for value-based health care initiatives, and are required for the completion of decision analysis studies.^[@bibr27-2325967119886591]^ Utilities are the underpinnings of cost-effectiveness analysis and have been a valuable source of clinical and economic guidance in sports medicine.^[@bibr28-2325967119886591][@bibr29-2325967119886591]--[@bibr30-2325967119886591]^

HRQoL is presented as a health state utility, with a scaled score between 0 and 1, where 0 is death (or the worst possible outcome) and 1 is perfect health.^[@bibr6-2325967119886591],[@bibr9-2325967119886591],[@bibr19-2325967119886591],[@bibr30-2325967119886591],[@bibr38-2325967119886591],[@bibr43-2325967119886591]^ HRQoL can be measured with health preference instruments, which incorporate patient personal preferences among health states and have the ability to capture additional quality-of-life dimensions not captured by standard patient-reported outcome measures (PROMs). Direct health preference calculation strategies include time trade-off,^[@bibr34-2325967119886591]^ standard gamble,^[@bibr34-2325967119886591]^ and feeling thermometer/visual analog rating scale.^[@bibr31-2325967119886591]^ These strategies can be used to directly calculate utilities for any given health state. To date, utility scores for patients with OCD of the knee are unknown.

The primary aim of the current study was to determine the utilities associated with 6 health states encountered during the spectrum of OCD treatment. The secondary aim was to determine whether utility scores differed with patient age, sex, or whether surgical treatment was required.

Methods {#section1-2325967119886591}
=======

Institutional review board approval was obtained before the study\'s initiation. Included patients were 10 to 20 years old at the time of interview. This age range was chosen to best encompass patients who are labeled as pediatric (younger than 20 years according to the American Academy of Pediatrics^[@bibr1-2325967119886591]^) and who are most frequently diagnosed with OCD rather than a normal developmental ossification radiographic variant, which is frequently seen in children younger than 10 years of age.^[@bibr46-2325967119886591]^ Patients underwent OCD treatment between 2010 and 2018. Patients presenting between June 2017 and March 2018 were identified prospectively by the treating surgeon at the time of diagnosis, and patients previously treated for OCD from January 2010 to May 2016 were identified by review of electronic billing records with the International Classification of Diseases 9th (732.7) and 10th (M93.261, M93.262) revision codes. Patients were excluded if they had an ipsilateral knee diagnosis concurrent with the OCD lesion (eg, fracture or patellar subluxation). Noncommunicative patients and those with neurologic, neuromuscular, or genetic syndromes (eg, Rubinstein-Taybi, cerebral palsy, nail-patella syndrome, arthrogryposis, hypophosphatemic rickets, autism, Down syndrome, and Charcot-Marie-Tooth) were excluded.

Three pediatric PROM scores were recorded prospectively in a subset of patients ([Figure 1](#fig1-2325967119886591){ref-type="fig"}) prior to treatment initiation to better understand the study cohort; however, these scores were not collected for the purpose of statistical comparison with the health state utilities, which measure a different construct. In younger patients (13 years and younger), parents were allowed to assist with PROM administration, but patients were required to give their own responses. No parental assistance was given for the health utility interviews, as these were administered verbally. For patients enrolled in person at our institution, paper consent was obtained directly from the patient if 18 years or older or from the parent with patient assent if younger than 18 years. Patients identified retrospectively were contacted and consented/assented via phone. Eligible patients were interviewed at a clinical appointment or over the phone, either after surgery or after the initiation of a nonoperative treatment plan. The patient inclusion/exclusion flowchart is displayed in [Figure 1](#fig1-2325967119886591){ref-type="fig"}.

![Patient inclusion/exclusion flowchart. HSS Pedi-FABS, Hospital for Special Surgery Pediatric Functional Activity Brief Scale; ICD, International Classification of Diseases; OCD, osteochondritis dissecans; PROMIS, Patient-Reported Outcomes Measurement Information System.](10.1177_2325967119886591-fig1){#fig1-2325967119886591}

Patient Utility Interviews {#section2-2325967119886591}
--------------------------

Vignettes for the 6 health states were presented ([Figure 2](#fig2-2325967119886591){ref-type="fig"}): symptomatic OCD lesion, nonoperative rehabilitation, postoperative rehabilitation, early degenerative changes, intermediate treatment success, and successful treatment. Health states were constructed per the joint consensus of 3 pediatric orthopaedic surgeons (E.R.D., D.W.G., and P.D.F.) who treat patients with OCD. Health utility vignettes were developed with guideline methodology from prior studies reporting on utilities in pediatric patients.^[@bibr36-2325967119886591]^ All patient interviews were conducted verbally by a single interviewer (J.A.) to ensure consistency and standardization of health state descriptions.

![Health states as described to patients. OCD, osteochondritis dissecans.](10.1177_2325967119886591-fig2){#fig2-2325967119886591}

Health utility scores for the 6 OCD health states were acquired with the feeling thermometer method,^[@bibr37-2325967119886591]^ owing to its demonstrated reliability for direct assessment of HRQoL in children and adolescents.^[@bibr15-2325967119886591],[@bibr37-2325967119886591],[@bibr42-2325967119886591]^ Participating patients were provided a description of each health state, presented in the same order, and were then asked to numerically rank their preference for each state from a scale of 0 to 100, with 100 being perfect health and 0 being equivalent to the worst health imaginable. Utilities obtained from the feeling thermometer (0-100) were converted to a score from 0 to 1 by dividing by 100 to convert utilities into the standardized format presented in previous studies.^[@bibr9-2325967119886591],[@bibr18-2325967119886591],[@bibr29-2325967119886591],[@bibr38-2325967119886591]^ Vignettes were presented in simple, pediatric patient--friendly language. For example,"Imagine that you had a painful knee, were having a hard time walking or running, felt there was occasional clicking or locking of the knee, and that you felt it got worse when you were being more active and limited your activity. You could not put weight on your knee, could not play any sports, and had to take pain medications such as Tylenol or daily ibuprofen. How would you rate this situation on a scale of 0 to 100, where 0 is the worst possible state imaginable and 100 is feeling perfect?"It was emphasized that the situations presented were hypothetical and that the score that patients were providing was not meant to capture their current state of health. The evaluation scale was reiterated at the end of every health state, and clarification was provided whenever necessary or as requested.

Clinical Data and Patient-Reported Outcomes {#section3-2325967119886591}
-------------------------------------------

For prospectively identified patients, the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Mobility (v 1.0),^[@bibr14-2325967119886591],[@bibr33-2325967119886591]^ the Hospital for Special Surgery Pediatric Functional Activity Brief Scale (HSS Pedi-FABS),^[@bibr11-2325967119886591]^ and the PROMIS Pain Interference (Version 1.0)^[@bibr14-2325967119886591],[@bibr32-2325967119886591]^ were collected at the clinical visit to further characterize the study cohort. Participants completed the questionnaires for their pretreatment functional status, pain, and physical activity level, as is standard of care at our institution. All questionnaires were completed electronically. PROMIS measures were completed with computer adaptive test forms.^[@bibr12-2325967119886591],[@bibr14-2325967119886591]^

Statistical Analysis {#section4-2325967119886591}
--------------------

In total, 100 patients were enrolled as recommended for utilities acquisition studies.^[@bibr43-2325967119886591]^ The Shapiro-Wilk test was used to test the normality of utility score distribution for each health state. Median and interquartile range (IQR) were reported for each health state utility score. Spearman correlation coefficients were calculated to assess the association of patient age on utility score assignments for each health state. Mann-Whitney *U* tests were used to evaluate the effect of patient sex or treatment (eg, whether treated with surgery or nonoperatively) on utility score assignments. Bonferroni correction was applied to all analyses to account for multiple comparisons; all analyses were 2-tailed, and significance level was set at *P* \< .05. Analyses were performed with SAS (Version 9.4; SAS Institute, Inc).

Results {#section5-2325967119886591}
=======

Study Demographics {#section6-2325967119886591}
------------------

Of the 100 patients, 74 were male. The median age at the time of survey was 15 years (IQR, 13-16.5 years). The median follow-up time from diagnosis to health utility collection was 2 years (IQR, 0.6-3.65 years). The most common location of OCD lesions was the medial femoral condyle (n = 51). Lesions of the lateral femoral condyle were the next-most prevalent (n = 20), followed by lesions of the trochlea (n = 16) and patellar defects (n = 13). Of the 100, 11 patients had bilateral OCD lesions, 66 patients underwent operative treatment for OCD, and 34 patients were treated nonoperatively. Surgical management techniques included transarticular OCD drilling, lesion fixation, combined treatment (OCD drilling and fixation), osteochondral autograft transfer, and autologous chondrocyte implantation procedures ([Table 1](#table1-2325967119886591){ref-type="table"}).

###### 

Patient Characteristics and Treatment Demographics*^a^*

![](10.1177_2325967119886591-table1)

  Variable                               n or Median (IQR)
  -------------------------------------- --------------------
  Patients                               100
   Female                                26
   Male                                  74
  Nonoperative                           34
  Operative                              66
   Transarticular drilling               24
   Internal fixation                     20
   Combination (drilling and fixation)   15
   Osteochondral autograft transfer      5
   Autologous chondrocyte implantation   2
  Age, y                                 
   At diagnosis                          13 (10-14)
   At surgery (n = 66)                   13 (11.25-15)
   At survey                             15 (13-16.25)
  Time from diagnosis to survey, y       2 (0.6-3.65)
  Patients with lesions                  
   Unilateral                            89
   Bilateral                             11
  OCD location                           
   Medial femoral condyle                51
   Lateral femoral condyle               20
   Trochlea                              16
   Patella                               13
  Patient-reported outcome measures      
   PROMIS Pediatric Mobility (n = 53)    38.6 (35.27-55.57)
   PROMIS Pain Interference (n = 49)     50 (37.55-55.84)
   HSS Pedi-FABS (n = 47)                21 (10.5-27.5)

*^a^*HSS Pedi-FABS, Hospital for Special Surgery Pediatric Functional Activity Brief Scale; IQR, interquartile range; OCD, osteochondritis dissecans; PROMIS, Patient-Reported Outcomes Measurement Information System.

Utility Calculations {#section7-2325967119886591}
--------------------

Utilities for the 6 health states are presented in [Table 2](#table2-2325967119886591){ref-type="table"}. There were no significant associations between any health state utility score and patient age, sex, or treatment ([Table 3](#table3-2325967119886591){ref-type="table"}).

###### 

OCD Health States and Calculated Utilities*^a^*

![](10.1177_2325967119886591-table2)

  Health State                     Utility, Median (IQR)
  -------------------------------- -----------------------
  Symptomatic OCD lesion           0.15 (0.05-0.25)
  Nonoperative rehabilitation      0.30 (0.20-0.50)
  Postoperative rehabilitation     0.30 (0.10-0.45)
  Early degenerative change        0.58 (0.50-0.70)
  Intermediate treatment success   0.65 (0.50-0.75)
  Successful treatment             1.0 (1.0-1.0)

*^a^*IQR, interquartile range; OCD, osteochondritis dissecans.

###### 

Associations Between Health State Utilities and Age, Sex, and Treatment*^a^*

![](10.1177_2325967119886591-table3)

  --------------------------------------------------------------------------------------------------------------------------------------------------------
                                   Age                    Sex, Median (IQR)   Treatment, Median (IQR)                                                
  -------------------------------- ---------------------- ------------------- ------------------------- ---------- ----- ------------- ------------- -----
  Symptomatic OCD                  --0.051\               .99                 0.10\                     15\        .99   0.15\         0.15\         .99
                                   \[--0.245 to 0.147\]                       (0-0.80)                  (0-55)           (0.05-0.25)   (0.07-0.25)   

  Nonoperative rehabilitation      --0.105\               .99                 0.40\                     30\        .87   0.35\         0.30\         .26
                                   \[--0.295 to 0.094\]                       (0-0.90)                  (0-80)           (0.15-0.40)   (0.20-0.50)   

  Postoperative rehabilitation     0.084\                 .99                 0.37\                     30\        .99   0.30\         0.30\         .99
                                   \[--0.114 to 0.276\]                       (0-0.70)                  (0-90)           (0.10-0.45)   (0.10-0.40)   

  Early degenerative change        0.184\                 .40                 0.60\                     55\        .99   0.60\         0.55\         .99
                                   \[--0.012 to 0.368\]                       (0.25-0.85)               (0-85)           (0.50-0.75)   (0.40-0.65)   

  Intermediate treatment success   --0.079\               .99                 0.70\                     60\        .51   0.68\         0.55\         .13
                                   \[--0.271 to 0.119\]                       (0.25-0.85)               (0-90)           (0.50-0.75)   (0.40-0.70)   

  Successful treatment             0.052\                 .99                 1.0\                      100\       .99   1.00\         1.00\         .99
                                   \[--0.146 to 0.246\]                       (0.80-1.0)                (70-100)         (1.00-1.00)   (0.95-1.00)   
  --------------------------------------------------------------------------------------------------------------------------------------------------------

*^a^*All *P* values are Bonferroni corrected. There were no associations between health utility assignments for any health state and patient age, sex, or treatment. IQR, interquartile range; OCD, osteochondritis dissecans.

Discussion {#section8-2325967119886591}
==========

The primary aim of the current study was to determine utility scores for 6 health states that a child, adolescent, or young adult may experience throughout the course of treatment of OCD of the knee. Patients with OCD assigned a low utility to the symptomatic health state (0.15). To put this into perspective, numerous studies have similarly shown a low health utility for symptomatic orthopaedic conditions in the pediatric population. Nwachukwu et al^[@bibr30-2325967119886591]^ demonstrated health state utilities as low as 0.3 in patients with symptomatic recurrent patellar dislocations. Low health state utility scores have also been computed for a number of chronic nonorthopaedic conditions affecting young people, including diabetes-associated end-stage kidney disease (0.51),^[@bibr20-2325967119886591]^ diabetes-associated stroke (0.23),^[@bibr20-2325967119886591]^ cerebral palsy (0.39),^[@bibr4-2325967119886591]^ hearing impairment (0.35),^[@bibr3-2325967119886591]^ and visual impairment (0.48).^[@bibr4-2325967119886591]^ While the health utility score does seem low, we do believe that 0.15 is a plausible number, specifically because children and adolescents may add significant negative weight to a symptomatic health state that precludes them from successfully performing activities of daily living and participating in sports/activities alongside their peer group.

There was a low and equivalent health utility assignment for patients undergoing rehabilitation either postoperatively or as part of a nonoperative treatment strategy. Patients assigned a utility score of 1.0 (perfect health) for achieving successful treatment and a utility score of 0.65 for the intermediate treatment success health state. These health utility scores were not associated with patient age, sex, or treatment (surgery vs nonoperative treatment), which supports the stability of these utility score calculations. To our knowledge, no previous studies have reported health state utilities for OCD of the knee. Documentation of utilities for health states related to the treatment of OCDs will be helpful in future decision analysis, HRQoL, and quality/safety/value studies on OCD.

Some recent studies have evaluated subjective and objective outcomes after knee OCD treatment in young patients, including subjective measurements of patient satisfaction.^[@bibr2-2325967119886591],[@bibr8-2325967119886591],[@bibr17-2325967119886591],[@bibr26-2325967119886591]^ Although these studies report rates of patient satisfaction with treatment, no health utility states were published that could be utilized for future studies. Despite the importance of having valid and clinically relevant health utility values for a given disease to perform decision analysis (eg, cost-effectiveness) research, to date, these values have not been elucidated for OCD. Rather, the only similar health utility publications report values for adults and for health states including end-stage osteoarthritis,^[@bibr6-2325967119886591],[@bibr18-2325967119886591],[@bibr38-2325967119886591]^ reactive and inflammatory arthritis,^[@bibr5-2325967119886591],[@bibr35-2325967119886591],[@bibr39-2325967119886591]^ and postarthroplasty surgery in active middle-aged adults.^[@bibr7-2325967119886591]^ These are neither applicable nor clinically relevant to the study of OCD in children, adolescents, and young adults, further underscoring the importance of the findings in the current study.

In future and ongoing investigations, the results of the current study may be combined with existing literature on treatment outcomes, surgical and nonoperative success and failure rates, and treatment cost to perform decision analysis studies for OCD treatment in young patients. Similar studies have recently been performed for anterior cruciate ligament surgery,^[@bibr23-2325967119886591],[@bibr40-2325967119886591],[@bibr41-2325967119886591]^ meniscal surgery,^[@bibr13-2325967119886591],[@bibr21-2325967119886591],[@bibr22-2325967119886591],[@bibr44-2325967119886591]^ cartilage repair,^[@bibr10-2325967119886591],[@bibr24-2325967119886591],[@bibr25-2325967119886591]^ and other sports medicine topics.^[@bibr28-2325967119886591]^ To encourage the widespread use of utility acquisition for HRQoL studies in orthopaedic surgery, standardized guidelines should be developed for the creation of vignettes for utilities acquisition for variable outcome-based conditions.

Health state utility studies have the ability to change clinical practice. Health state utilities give clinicians quantifiable insight into the aggregated perspectives of a patient cohort beyond the breadth of PROMs by sampling patients' preferences outside the context of their own health state. In context, health utilities can be used as an adjunct to align surgeon as well as patient goals and expectations. To date, however, no health state utility studies have been performed evaluating OCD lesion treatment strategies, owing to a lack of health state utility data.

Limitations of the current study include the potential for response bias with the use of the feeling thermometer instrument, wherein participants may be reluctant to utilize the extreme ends of the scale.^[@bibr45-2325967119886591]^ However, the feeling thermometer provided a simple, easy-to-comprehend framework for pediatric patients to directly provide health state preferences. The feeling thermometer has been similarly used successfully in previous studies involving children and adolescents.^[@bibr15-2325967119886591],[@bibr37-2325967119886591],[@bibr42-2325967119886591]^ While we provided detailed descriptions of the 6 health states, we had concerns that patients who did not experience 1 or more of the described health states (such as physical therapy or surgical management) may have had a different understanding of those health states as compared with participants who actually experienced that health state during their treatment. However, treatment strategy was not associated with patients' health utility assignments in this study, arguing in favor of the stability of these health state utility assignments regardless of treatment strategy. This was important because patients were interviewed in various stages of treatment. Also, because these patients were otherwise healthy and did not have any other acute or chronic health conditions, they may have overstated the impact of OCD and rated a lower health utility than that of children who had OCD within a perspective of another chronic health condition. However, children who present with OCD are frequently otherwise healthy; therefore, the effect of OCD on the health utility states of the study cohort is likely representative of the population at large. One noted limitation of our study was the variability in time and location where patients were interviewed, which also varied in relation to the timing of treatment. However, all patients were interviewed by a single interviewer, and health state scenarios were presented via identical vignette templates. Additionally, it was emphasized that utility vignette scenarios were hypothetical and therefore independent of the actual treatment received by any individual.

The 3 variables included in the analysis of the stability of the health utility ratings (age, sex, and treatment strategy) represent those from the study that have the most clinical relevance to affecting the patient experience. Future studies might consider testing the stability of health state constructs against additional factors. Although PROMs and health utility state assignments measure distinct constructs, future studies may seek to investigate the relationship between appropriate PROMs and health utilities. In the current cohort, PROM scores were primarily collected during routine follow-up patient visits as a means of clinically tracking clinical progression. Future studies should further establish the impact of PROM-quantified disease burden on health utility assignment.

Conclusion {#section9-2325967119886591}
==========

The current study provides health utilities for 6 health states encountered in the diagnosis and treatment of OCD of the knee in children, adolescents, and young adults. By providing these scores, future research can be performed to quantify the net benefit of various treatment and outcome modalities relative to baseline symptomatic health states, specifically through decision analysis, HRQoL, and quality/safety/value studies. These studies have the potential to change clinical practice. The utility scores reported in this study were stable in that they were not affected by patient age, sex, or treatment strategy.
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